SGS helps pharma and biotech sponsors run IDMC clinical trials with independent unblinded analysis, validated reporting workflows and structured committee coordination, so safety and interim decisions are based on clear, reliable information.
With 10+ years of IDMC experience and 100+ meetings annually, we understand the operational, statistical and human dynamics behind effective committee oversight.
Quality is built from the start. We focus on early setup, test runs and validated workflows before IDMC timelines becomes critical.
IDMC support depends on confidence in independent processes. We set up clear separation between blinded and unblinded teams to protect trial integrity.
Committee members need clarity, not volume. We help turn complex trial data into focused review packages that support informed recommendations.
A well-prepared setup often determines how smoothly and efficiently decisions can be reached under pressure.
Paul De Souza
Business Development Manager, SGS
VP Clinical development, argenx
Sabine Coppieters
From my perspective, SGS handles the argenx IDMCs very effectively. The operational coordination of the multiple committees is strong and reliable and communication is clear and well organized.
"
IDMC document development
Authoring and reviewing essential IDMC documents such as IDMC charter, SAP, shell TLFs and recommendation form.
Unblinded statistical analysis
Independent statisticians prepare validated unblinded outputs for safety reviews, interim analyses and IDMC meetings.
IDMC reporting package
Prepare the tables, listings, figures and narratives needed for focused committee review.
Programming and validation
Build, test and validate reporting workflows in SAS, R or hybrid environments, including sponsor code, SGS code or shared models.
Meeting coordination
Organize agendas, materials, attendance, minutes, signatures and follow-up actions to keep the process moving smoothly.
Recommendation documentation
Capture committee recommendations clearly, so sponsors receive decisions that are documented, actionable and properly filed.
An Independent Data Monitoring Committee, or IDMC, reviews unblinded safety and efficacy data during an ongoing clinical trial. Its role is to protect patient safety, preserve scientific integrity and recommend whether a study should continue as planned, be adapted or stop.
For sponsors, the challenge is practical as much as scientific. The right data must be ready on time, the study blind must remain protected and committee members need a clear, reliable data package. SGS supports that full process, either as a standalone independent CRO or through a structurally separated unblinded team in a full-service model.
We work with SAS, R or hybrid environments, aligned with sponsor needs and study-specific workflows for a cost-efficient IDMC setup.
We're a mid-sized, full-service CRO specialized in early-phase development and biometrics. We offer drug development consultancy, project management, monitoring, data management, statistics, medical writing, safety and regulatory services. We have our own clinical pharmacology unit in Belgium featuring a viral challenge facility and have access to patients through our site network with 400+ sites. Our key therapeutic areas include infectious diseases, vaccines, respiratory, dermatology and oncology.